Mulpleta (lusutrombopag) / Shionogi  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mulpleta (lusutrombopag) / Shionogi
NCT06287567: Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

Not yet recruiting
4
17
RoW
Lusutrombopag Oral Tablet, MULPLETA®, S-888711
Institute of Hematology & Blood Diseases Hospital, China
Idiopathic Thrombocytopenic Purpura, Immune Thrombocytopenia
09/24
11/24
NCT06426043: A Prospective Study on the Treatment of Recurrent/Refractory/Intolerable NSAA With Lusutrombopag

Not yet recruiting
4
40
RoW
Lusutrombopag
Peking Union Medical College Hospital
Aplastic Anemia
06/25
08/25

Download Options